Recent Advances in Peptide Drug Discovery

DATE

September 21, 2023

TIME

8:00 a.m. PDT / 11:00 a.m. EDT / 16:00 BST / 17:00 CEST - Duration: 60 Minutes

Overview

Peptides, and in particular macrocyclic peptides, are well known for their ability to disrupt protein-protein interactions (PPIs). However, it's challenging to screen for and discover novel macrocyclic peptides. High throughput screening compound collections generally include few such molecules, and other techniques are limited to macrocycles comprised of naturally occurring (or similar) amino acids.

In this presentation we will discuss the use of DNA encoded libraries to discover peptide macrocycles that disrupt PPIs and provide a case study employing the oncoprotein murine double minute 2 (MDM2). We will also highlight the advantages of DEL compared to other methods, which includes the ability to use unnatural amino acids. This provides greater chemical diversity with smaller ring sizes and facilitates subsequent hit development as it pertains to beneficial PK properties.

Key Learning Objectives:

Learn the potential advantages of using DEL for discovering cell-permeable cyclic peptides
Learn the basics of how such DELs are designed and the current status of the field
Learn how to follow up on DEL hits and some discussion of emerging techniques
Get a sense of timelines and difficulties that exist when conducting such a screen

Who Should Attend:

Researchers interested in macrocyclic peptides, in particular cell permeable peptides
Researchers struggling to find chemical matter capable of inhibiting PPIs

Brought to you by:

Speakers

Alex Satz
Executive Director, Head of WuXi Biology DB Europe,
WuXi AppTec

Anthony Silvestri
Head of Discovery Chemistry,
Unnatural Products

Catherine Dold
Health & Environment Writer,
C&EN Media Group

Registration

Forwarded this event? Clear the form

Work Email Address*

Salutation

First Name*

Last Name*

Company*

Job Title*

Address 1

City

State*

Zip / Post Code

Country*

Business Phone

Yes, I’m interested in learning how DNA encoded library screening can identify new chemical matter capable of inhibiting protein-protein interactions

Yes, I am interested in macrocyclic peptides

Yes, I would like more information on WuXi AppTec’s peptide discovery services

I would like to receive more information on products and services from the American Chemical Society

*By submitting this form, you agree to receive more information on related products and services from the American Chemical Society (ACS Publications) and its sponsor via email. ACS takes your privacy seriously. For more information, please see the ACS Privacy Policy.

View On Demand Webinars